. home.aspx
EVENTS
Cell Biology 2020
CELL BIOLOGY 2020
September 23-23, 2020
Cell Biology 2020 Virtual Event will continue to create a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment, to study cells cells – their physiological properties, structure, the organelles they contain, environmental interactions, life cycle, ...

Biotechnology and Biomaterials
BIOTECHNOLOGY AND BIOMATERIALS
August 20-21, 2020
The key intention of Biotechnology and Biomaterials-2020 is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world.

Advances in Stem Cell Research and Regenerative medicine
ADVANCES IN STEM CELL RESEARCH AND REGENERATIVE MEDICINE
May 29-30, 2020
The aim of this global conference is to promote the recent advances in Stem Cell Therapy Research with its applications as well as the cell and gene therapy which stands as the new therapeutic approaches.

C-SUITE ON DECK

home.aspx
   

Q&A With Sangram Vajre, Co-Founder & Chief Evangelist At Terminus

January 09, 2020 / MEDIA 7
SHARESHARESHARE
Sangram Vajre, Co-Founder & Chief Evangelist at Terminus is also an author and host of the podcast FlipmyFunnel. He is one of the leading minds in B2B marketing.

MEDIA 7: What are you passionate about?
SANGRAM VAJRE:
Three things: Lead professionally. Grow personally. Love family.

M7: Terminus has been recognized as one of Georgia’s 40 fastest-growing companies by ACG Atlanta. What factors contribute to this pace?
SV: 
One of our core values is #OneTeam – which means we think and act as one team and know that if we treat our team right, they will treat our customers amazing. There are no great companies, only great people that make those companies.

"Marketers who say they are going to transform their organization without support from Sales and buy-in from management fail to see success."

M7: Terminus is the leader of the account-based movement. What according to you are the common mistakes marketers make with ABM?
SV:
 Marketers who say they are going to transform their organization without support from Sales and buy-in from management fail to see success. The marketers who make a few sales people wildly successful, join campaigns to help them win deals, win their hearts and minds.

M7: Could you tell us a little bit about your podcast Flipmyfunnel? How did that idea come about?
SV:
 I was already talking to customers and amazing people in the industry and every time I would walk away with the thought that wish I recorded that conversation. Well, I just started doing that which turned into a podcast series that has now over 500 episodes and continue to rate in the top 50 business podcast.

"Terminus can quickly get a sales rep alerted when their target account is on the website which helps them prioritize which target accounts they need to spend more time with."

M7: What are some of the best indicators that a prospect is really engaged with your brand?
SV:
Visit to your website and the frequency of it. There are technologies like Terminus that can quickly get a sales rep alerted when their target account is on the website which helps them prioritize which target accounts they need to spend more time with. This could become one of the most important indicators of early success for companies in 2020.


M7: What marketing channels do you use and which ones do you see as the most promising given your target customers?
SV:
It’s always the combination that works since everyone is different but the goal is to surround them with your message on their channels so when they are ready, they think of you.

"Mature and forward thinking CMOs are starting to help their sales team win more and faster by focusing on pipeline velocity and expansion deals."

M7: What aspects of ABM do you think might change in the future?
SV:
I believe ABM is B2B. Most companies are still focused on top of the funnel. Mature and forward thinking CMOs are starting to help their sales team win more and faster by focusing on pipeline velocity and expansion deals.


M7: What is your favorite quote?
SV:
Selling is essentially transfer of feelings – Zig Ziglar.


About Terminus


Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revolutionize the way B2B marketing is done. Hundreds of organizations worldwide, including Salesforce, GE, Verizon, 3M and CA Technologies, turn to Terminus to more effectively target, engage and grow their best-fit accounts. Terminus offers savvy marketers the technology and proven expertise to radically improve ABM strategies and campaigns, increasing ROI and producing exceptional results. For more information, visit Terminus.

SPOTLIGHT

Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revoluti...

RELATED NEWS


From Minuteman HS:Minuteman High School has landed another major grant from the Massachusetts Life Sciences Center to help upgrade its Biotechnology program. The $108,172 competitive grant will enable the school to outfit its Biotechnology lab with more advanced equipment and send two Biotechnology teachers to intensive training in the latest biomanufacturing techniques....
PATCH.COM
READ MORE

Self-fertilization is a problem, as it leads to inbreeding. Recognition systems that prevent self-fertilization have evolved to ensure that a plant mates only with a genetically different plant and not with itself. The recognition systems underlying self-incompatibility are found all around us in nature and can be found in at least 100 plant families and 40 percent of species. Until now, however, researchers have not known how the astonishing diversity in these systems evolves. A team of researc...

READ MORE

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have figured out a better way to deliver a DNA editing tool to shorten the presence of the editor proteins in the cells in what they describe as a "hit and run" approach. CRISPR (clustered regularly interspaced short palindromic repeats) technology is used to alter DNA sequences and modify gene function. CRISPR/Cas9 is an enzyme that is used as a pair of scissors to cut two strands of DNA at a specific location to add, ...

READ MORE

Double-blind, randomized placebo-controlled clinical trials are highly challenging and resource-intensive. Drug-development costs have risen dramatically over time, yet success rates have not improved1. In parallel, rates of placebo response across multiple therapeutic areas are at historic highs and progressively increasing2. Multiple reviews in different therapeutic areas, including pain3, epilepsy4, Crohn’s disease5, schizophrenia6, and others suggest a worsening trend - year over year,...
FIERCEBIOTECH
READ MORE

Scientists at Scripps Research in Florida report that they have discovered a biological system that manages cells response to opioid drug exposure. The team said its discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications. In a paper Genetic behavioral screen identifies an orphan anti-opioid system published in Science, lead authors Kirill Martemyanov, PhD, and Brock Grill, PhD, described how they designed and implemented a...

READ MORE

A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a specific mutation in a gene called CEP290. This mutation causes the RNA transcript of the gene to have the wrong three-dimensional structure, blocking its translation into a protein. This, in turn, causes ...

READ MORE

SPOTLIGHT

Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revoluti...

RESOURCES

EVENTS

Cell Biology 2020
CELL BIOLOGY 2020
September 23-23, 2020
Cell Biology 2020 Virtual Event will continue to create a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment, to study cells cells – their physiological properties, structure, the organelles they contain, environmental interactions, life cycle, ...

Biotechnology and Biomaterials
BIOTECHNOLOGY AND BIOMATERIALS
August 20-21, 2020
The key intention of Biotechnology and Biomaterials-2020 is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world.

Advances in Stem Cell Research and Regenerative medicine
ADVANCES IN STEM CELL RESEARCH AND REGENERATIVE MEDICINE
May 29-30, 2020
The aim of this global conference is to promote the recent advances in Stem Cell Therapy Research with its applications as well as the cell and gene therapy which stands as the new therapeutic approaches.